+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Stable Isotope Labeled Compounds Market, By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others), By Application, By Substances, By Indication, By Method, By End-User, By Region, Forecast & Opportunities, 2025

  • ID: 5031367
  • Report
  • May 2020
  • Region: Global
  • 114 pages
  • TechSci Research
UP TO OFF
until Jul 31st 2020
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Rising Cancer Cases is One of the Major Factors for the Growth of Global Stable Isotope Labeled Compounds Market.

FEATURED COMPANIES

  • 3M
  • BOC Sciences
  • CortecNet
  • ISOFLEX
  • Medical Isotopes, Inc.
  • Mesbah Energy Co.
  • MORE
The Global Stable Isotope Labeled Compounds Market is expected to grow at a steady CAGR during the forecast period. These compounds are used to check the isotope pathway during a chemical metabolism or to detect any isotopic presence in the cells. Thus, they are generally used in biomedical research and the R&D sector, which is a major factor contributing to the growth of the market. The rising cancer cases and the increasing number of pharma and biotech companies is one of the major factors for the market growth. However, the inability to buy these compounds due to their costliness is a reason which might act as a restraint to the market.

The Global Stable Isotope Labeled Compounds Market is segmented based on compounds, application, substances, indication, method, end-user and region. The end-user segment is further fragmented into pharmaceutical and biotechnology companies, academic institute and others, out of which the pharmaceutical and biotechnology companies segment is expected to be the fastest growing segment in 2019, due to the increasing researches based on these compounds.

Based on region, the Global Stable Isotope Labeled Compounds Market can be segmented into Asia-Pacific, Europe, North America, South America, and Middle East & Africa. As of 2019, North America held the largest market share on the back of the presence of various stable isotope-based research companies and an economy good enough to carry out the R&D procedures in those companies.

Major players of the Global Stable Isotope Labeled Compounds Market include PerkinElmer, Merck, 3M, Cambridge Isotope Laboratories, Inc., URENCO Limited, IsoSciences LLC, Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, Alsachim, Taiyo Nippon Sanso Corporation, CortecNet, ISOFLEX, Huayi Isotopes Co., Mesbah Energy Co., C/D/N/ Isotope Inc., Shoko Co. Ltd., Nordion Inc., BOC Sciences, Pepscan, etc.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and forecast the market size of the Global Stable Isotope Labeled Compounds Market.
  • To classify and forecast the Global Stable Isotope Labeled Compounds Market based on compounds, application, substances, indication, method, end-user, region and company.
  • To identify drivers and challenges for the Global Stable Isotope Labeled Compounds Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Stable Isotope Labeled Compounds Market.
  • To conduct pricing analysis for the Global Stable Isotope Labeled Compounds Market.
  • To identify and analyze the profile of leading players operating in the Global Stable Isotope Labeled Compounds Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of manufacturers across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the manufacturers which could not be identified due to the limitations of secondary research. The author analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Stable Isotope Labeled Compounds Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Stable isotope labeled compounds manufacturers, suppliers, distributors and other stakeholders
  • Biotechnology and pharma companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to stable isotope labeled compounds
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Stable Isotope Labeled Compounds Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Compounds:
  • Carbon (13C)
  • Nitrogen(15N)
  • Deuterium
  • Oxygen(18O)
  • Others
Market, By Application:
  • Diagnosis
  • Drug Discovery
  • Imaging
  • Sterilization
  • Others
Market, By Substances:
  • Nucleic Acids
  • Amino Acids
  • Drugs/Metabolites
  • Fatty Acids/Lipids
  • NMR Solvents
  • Others
Market, By Indication:
  • Cardiology
  • Neurology
  • Inflammation
  • Metabolic disease
  • Others
Market, By Method:
  • Chemical
  • Cell-culturing
Market, By End-User:
  • Pharmaceutical and Biotechnology Companies
  • Academic Institute
  • Others
Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Russia
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle east & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Stable Isotope Labeled Compounds Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. If you buy the ‘Multi-user’ License of this report before June 2020, you will get a free update in form of market data excel sheet within 3 to 6 months of your purchase on request.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M
  • BOC Sciences
  • CortecNet
  • ISOFLEX
  • Medical Isotopes, Inc.
  • Mesbah Energy Co.
  • MORE
1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Stable Isotopes Labeled Compounds Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others)
5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
5.2.5. By Method (Chemical, Cell-culturing)
5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index

6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Compounds
6.2.2. By Application
6.2.3. By Substances
6.2.4. By Indication
6.2.5. By Method
6.2.6. By End-User
6.2.7. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Stable Isotopes Labeled Compounds Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Compounds
6.4.1.2.2. By Application
6.4.1.2.3. By Substances
6.4.1.2.4. By Indication
6.4.1.2.5. By Method
6.4.1.2.6. By End-User
6.4.2. India Stable Isotopes Labeled Compounds Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Compounds
6.4.2.2.2. By Application
6.4.2.2.3. By Substances
6.4.2.2.4. By Indication
6.4.2.2.5. By Method
6.4.2.2.6. By End-User
6.4.3. Japan Stable Isotopes Labeled Compounds Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Compounds
6.4.3.2.2. By Application
6.4.3.2.3. By Substances
6.4.3.2.4. By Indication
6.4.3.2.5. By Method
6.4.3.2.6. By End-User
6.4.4. South Korea Stable Isotopes Labeled Compounds Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Compounds
6.4.4.2.2. By Application
6.4.4.2.3. By Substances
6.4.4.2.4. By Indication
6.4.4.2.5. By Method
6.4.4.2.6. By End-User
6.4.5. Singapore Stable Isotopes Labeled Compounds Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Compounds
6.4.5.2.2. By Application
6.4.5.2.3. By Substances
6.4.5.2.4. By Indication
6.4.5.2.5. By Method
6.4.5.2.6. By End-User
6.4.6. Australia Stable Isotopes Labeled Compounds Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Compounds
6.4.6.2.2. By Application
6.4.6.2.3. By Substances
6.4.6.2.4. By Indication
6.4.6.2.5. By Method
6.4.6.2.6. By End-User

7. Europe Stable Isotopes Labeled Compounds Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Compounds
7.2.2. By Application
7.2.3. By Substances
7.2.4. By Indication
7.2.5. By Method
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Stable Isotopes Labeled Compounds Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Product
7.4.1.2.2. By Compounds
7.4.1.2.3. By Application
7.4.1.2.4. By Substances
7.4.1.2.5. By Indication
7.4.1.2.6. By Method
7.4.1.2.7. By End-User
7.4.2. Germany Stable Isotopes Labeled Compounds Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Compounds
7.4.2.2.2. By Application
7.4.2.2.3. By Substances
7.4.2.2.4. By Indication
7.4.2.2.5. By Method
7.4.2.2.6. By End-User
7.4.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Compounds
7.4.3.2.2. By Application
7.4.3.2.3. By Substances
7.4.3.2.4. By Indication
7.4.3.2.5. By Method
7.4.3.2.6. By End-User
7.4.4. Italy Stable Isotopes Labeled Compounds Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Compounds
7.4.4.2.2. By Application
7.4.4.2.3. By Substances
7.4.4.2.4. By Indication
7.4.4.2.5. By Method
7.4.4.2.6. By End-User
7.4.5. Russia Stable Isotopes Labeled Compounds Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Compounds
7.4.5.2.2. By Application
7.4.5.2.3. By Substances
7.4.5.2.4. By Indication
7.4.5.2.5. By Method
7.4.5.2.6. By End-User
7.4.6. Spain Stable Isotopes Labeled Compounds Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Compounds
7.4.6.2.2. By Application
7.4.6.2.3. By Substances
7.4.6.2.4. By Indication
7.4.6.2.5. By Method
7.4.6.2.6. By End-User

8. North America Stable Isotopes Labeled Compounds Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Compounds
8.2.2. By Application
8.2.3. By Substances
8.2.4. By Indication
8.2.5. By Method
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Stable Isotopes Labeled Compounds Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Compounds
8.4.1.2.2. By Application
8.4.1.2.3. By Substances
8.4.1.2.4. By Indication
8.4.1.2.5. By Method
8.4.1.2.6. By End-User
8.4.2. Mexico Stable Isotopes Labeled Compounds Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Compounds
8.4.2.2.2. By Application
8.4.2.2.3. By Substances
8.4.2.2.4. By Indication
8.4.2.2.5. By Method
8.4.2.2.6. By End-User
8.4.3. Canada Stable Isotopes Labeled Compounds Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Compounds
8.4.3.2.2. By Application
8.4.3.2.3. By Substances
8.4.3.2.4. By Indication
8.4.3.2.5. By Method
8.4.3.2.6. By End-User

9. South America Stable Isotopes Labeled Compounds Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Compounds
9.2.2. By Application
9.2.3. By Substances
9.2.4. By Indication
9.2.5. By Method
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Stable Isotopes Labeled Compounds Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Compounds
9.4.1.2.2. By Application
9.4.1.2.3. By Substances
9.4.1.2.4. By Indication
9.4.1.2.5. By Method
9.4.1.2.6. By End-User
9.4.2. Argentina Stable Isotopes Labeled Compounds Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Compounds
9.4.2.2.2. By Application
9.4.2.2.3. By Substances
9.4.2.2.4. By Indication
9.4.2.2.5. By Method
9.4.2.2.6. By End-User
9.4.3. Colombia Stable Isotopes Labeled Compounds Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Compounds
9.4.3.2.2. By Application
9.4.3.2.3. By Substances
9.4.3.2.4. By Indication
9.4.3.2.5. By Method
9.4.3.2.6. By End-User

10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Compounds
10.2.2. By Application
10.2.3. By Substances
10.2.4. By Indication
10.2.5. By Method
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Stable Isotopes Labeled Compounds Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Compounds
10.4.1.2.2. By Application
10.4.1.2.3. By Substances
10.4.1.2.4. By Indication
10.4.1.2.5. By Method
10.4.1.2.6. By End-User
10.4.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Compounds
10.4.2.2.2. By Application
10.4.2.2.3. By Substances
10.4.2.2.4. By Indication
10.4.2.2.5. By Method
10.4.2.2.6. By End-User
10.4.3. UAE Stable Isotopes Labeled Compounds Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Compounds
10.4.3.2.2. By Application
10.4.3.2.3. By Substances
10.4.3.2.4. By Indication
10.4.3.2.5. By Method
10.4.3.2.6. By End-User

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. PerkinElmer
13.2.2. Merck
13.2.3. 3M
13.2.4. Cambridge Isotope Laboratories, Inc.
13.2.5. URENCO Limited
13.2.6. IsoSciences, LLC
13.2.7. Medical Isotopes, Inc.
13.2.8. Omicron Biochemicals, Inc.
13.2.9. Trace Sciences International
13.2.10. Alsachim
13.2.11. Taiyo Nippon Sanso Corporation
13.2.12. CortecNet
13.2.13. ISOFLEX
13.2.14. Huayi Isotopes Co
13.2.15. Mesbah Energy Co.
13.2.16. C/D/N/ Isotope Inc.
13.2.17. Shoko Co. Ltd.
13.2.18. Nordion Inc.
13.2.19. BOC Sciences
13.2.20. Pepscan

14. Strategic Recommendations

15. About the author & Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • PerkinElmer
  • Merck
  • 3M
  • Cambridge Isotope Laboratories, Inc.
  • URENCO Limited
  • IsoSciences, LLC
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • Trace Sciences International
  • Alsachim
  • Taiyo Nippon Sanso Corporation
  • CortecNet
  • ISOFLEX
  • Huayi Isotopes Co
  • Mesbah Energy Co.
  • C/D/N/ Isotope Inc.
  • Shoko Co. Ltd.
  • Nordion Inc.
  • BOC Sciences
  • Pepscan
Note: Product cover images may vary from those shown
Adroll
adroll